ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

NMR Based etabolomics: An Exquisite and Facile Method for Evaluated Therapeutic Efficacy and Screening Drug Toxicity

Guleria, Anupam*; Kumar, Amit; Kumar, Umesh; Raj, Ritu; Kumar, Dinesh*
CURRENT TOPICS IN MEDICINAL CHEMISTRY2018DOI: 10.2174/1568026619666181120141603
20被引1阅读
引用收藏
分享

摘要

Metabolomics is an analytical approach to metabolism and involves quantitative and comparative analysis of low-molecular-weight metabolites in body fluids or cellular/tissues extracts. Owing to its ability to reveal disease-specific metabolic patterns or metabolic changes produced in response to a therapeutic intervention; it is gaining widespread applications virtually in all aspects of biomedical and pharmaceutical research pertaining to human healthcare management. It has also started playing a strategic role in pharmacological and toxicological research for evaluating therapeutic efficacy/safety of promising drug candidates either alone or in conjunction with other omics tools such as genomics, transcriptomics and proteomics. The metabolic profiling capabilities of nuclear magnetic resonance (NMR) spectroscopy along with pattern recognition methods have successfully been applied for identifying a diagnostic panel of biomarkers, evaluating drug efficacy/safety, screening toxicity and disease mechanism. Particularly, the interest in applying NMR-based metabolomics for the assessment of therapeutic efficacy and safety is increasing among drug researchers and drug regulators owing to its nondestructive, non-selective and minimal sample preparation requirement. On top of this, it offers the potential for high-throughput (i.e. >100 samples a day is attainable) and provides highly reproducible results. In this review, we will discuss some of the recent developments related to NMR based metabolomics followed by some recent literature examples to highlight its potential in (a) the evaluation of therapeutic efficacy and safety of lead discovery compounds, (b) monitoring disease status and recovery after treatment and (c) identification and evaluation of biomarkers of systemic/organ-specific toxicity. Additionally, the review will also highlight its role to facilitate clinical trial testing and improve post-approval drug monitoring.

学科与关键词

关键词
Nuclear magnetic resonanceMetabolomicsPharmacometabolomicsToxicometabolomicsClinical metabolomicsDrug toxicity
相关
加载中…
  • Potential of metabolomics in preclinical and clinical drug development
    Kumar, Baldeep; Prakash, Ajay; Ruhela, Rakesh Kumar; Medhi, Bikash*Pharmacological Reports, 2014, 66(6): 956-963.被引 29
  • The assessment of plant metabolite profiles by NMR-based methodologies
    Holmes, Elaine; Tang, Huiru; Wang, Yulan; Seger, Christoph*Planta Medica, 2006, 72(9): 771-785.被引 108
  • Nuclear magnetic resonance-based metabolomics for prediction of gastric damage induced by indomethacin in rats
    Um, So Young; Park, Jung Hyun; Chung, Myeon Woo; Kim, Kyu-Bong; Kim, Seon Hwa; Choi, Ki Hwan; Lee, Hwa Jeong*Analytica Chimica Acta, 2012, 722: 87-94.被引 19
查看全部 →

发表信息

论文状态
公开发表
期刊
CURRENT TOPICS IN MEDICINAL CHEMISTRY
发表日期
2018
卷期
第 18 卷, 第 20 期
页码
1827-1849
DOI
10.2174/1568026619666181120141603
语言
ENGLISH
期刊等级
Q2
成果收录
SCIE
资助标注
Department of Science and Technology (DST), Govt. of India under DST INSPIRE Faculty Award [DST/Inspire Faculty Award 2014/LSBM-120]; Department of Medical Education, Govt. of Uttar Pradesh

作者

  • G

    Guleria, Anupam (通讯) (第一作者)

  • K

    Kumar, Amit

查看全部 5 位作者收起作者
  • K

    Kumar, Umesh

  • R

    Raj, Ritu

  • K

    Kumar, Dinesh (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417